|
Zhi-Hong
Su, Ji-Cheng Li, Department of Histology and Embryology,
Zhejiang University Medical College, Hangzhou 310031, Zhejiang
Province, China
Correspondence to: Dr. Ji-Cheng Li, Department of Histology
and Embryology, Zhejiang University Medical College, Hangzhou
310031, Zhejiang Province, China.
lijc@mail.hz.zj.cn
Telephone: +86-571-87217451
Fax: +86-571-87217139
Received: 2004-02-02
Accepted: 2004-02-21
Abstract
AIM: To investigate the pathogenic mechanism of colon cancer at
the molecular level and to elucidate the relationship between
intercellular adhesion molecule-1 (ICAM-1) and nm23H1
genes and Chinese patients with colon cancer.
METHODS: DNA was extracted from paraffin-embedded materials.
Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP)
was used to analyze MSI and LOH. Expression of ICAM-1 was detected
by Envision immuno-histochemistry. Experimental results were
analyzed with Leica-Qwin computer imaging techniques and SPSS
software of statistics.
RESULTS: ICAM-1 expression of lymphatic endothelium was negative in
normal colon and positive in colon cancer respectively. The number
of lymphatics positive for ICAM-1 was gradually increased with
degree of cancer invasion (P<0.01). In the group with
metastasis of colon cancer, the number of lymphatics positive for
ICAM-1 in lymph nodes was more than that in the group with no
metastasis (P<0.01). The frequency of MSI, LOH and nm23H1
protein was 26.67%, 20.00% and 53.33% in colon cancer, respectively.
In TNM staging, MSI (43.75%) and nm23H1 protein (81.25%) in stages
I+II were detected more easily than the corresponding indexes (MSI:
7.14%, P<0.05 and nm23H1: 21.43%, P<0.01) in
stages III+IV. By comparison, the frequency of LOH (35.71%) in
stages III+IV was more than that of LOH (6.25%, P<0.05) in
stages I+II. LOH exhibited a rising trend along with the Duke’s
staging. nm23H1 protein in the group of tubular
adenocarcinoma (60.00%) was higher expressed than that in the group
of mucoid adenocarcinoma (20.00%) (P<0.01), and exhibited
a rising trend with the differentiation degrees of tubular
adenocarcinoma. nm23H1 protein in MSI positive group was
higher expressed (75%) than that in MSI negative group (45.45%, P<0.05).
CONCLUSION: The expression of ICAM-1 in lymphatic vessels is
beneficial to the judgement of the invasion and metastasis ability
of colon cancer and the anti-tumor immunity function, and shows an
important clinical significance in predicting lymphatic metastasis
of colon cancer. MSI and LOH may separately control the development
of sporadic colon cancer with different pathways. LOH mostly arises
in the late period of sporadic colon cancer and endows a high
aggressive and poor prognostic phenotype. By compassion, MSI may be
an early period molecule marker for sporadic colon cancer, enhanced
expression of nm23H1 protein can effectively inhibit
colon cancer metastasis and improve prognosis of sporadic colon
cancer patients.
Su ZH, Li JC.
Lymphatic metastasis and nm23H1 genetic instability in
Chinese colon cancer patients. World J Gastroenterol
2004; 10(19): 2800-2804
http://www.wjgnet.com/1007-9327/10/2800.asp
INTRODUCTION
Colon cancer is one of the common malignant tumors. A series of
investigations have revealed that the main reason why it gives rise
to death of patients lies in its invasiveness and metastasis[1].
Therefore, preventing colon deterioration and decreasing the death
rate of colon cancer is of great significance. So far, it has been
known that many factors may have an influence on colon cancer, such
as anti-oncogenes, adhesion molecular E-selectin and E-cadherin,
vascular endothelial growth factor and matrix metal protein (MMP-2)[2-5].
Among these factors, anti-oncogene and adhesion molecules have
become the "hot
spots" in research of colon cancer[6-8].
Intercellular adhesion
molecule-1 (ICAM-1), an important transmembrane glycoprotein, is
negatively expressed on endothelial cells of lymphatic vessels in
normal conditions[9, 10]. ICAM-1 could induce attachment
of cells such as lymphocytes to endothelial cells of blood vessels,
and traverse blood vessels, aggregate antigens and take part in
immune and inflammatory reactions. When tumors appeared in the body,
lymphatic vessels became the main pathway for tumor cells to be
transferred as a result of their own permeability[11]. In
the process, recognition, adhesion, morphologic change and
penetration between cells were involved. Vasse et al.[12].
reported that breast cancer cells could over-express the specific
ligands of ICAM-1 (lymphocyte function associated antigen 1, LFA-1).
With the development of cancer, the expression of LFA-1 went to an
ascending trend on cancer cells. All the results indicated that
ICAM-1 might take part in the metastasis. How endothelial cells of
lymphatic vessels express ICAM-1? Few reports are available about
whether endothelial cells of lymphatics express ICAM-1 or not in
cancer tissue and whether ICAM-1/LFA-1 take part in the process of
cancer cells attached to endothelial cells of lymphatics and
metastasis.
nm23H1 is one
of the main anti-oncogenes. A great number of experiments indicated
that inactivation of these genes, that is, genetic instability,
resulted in metastasis[13,14]. However, there were few
researches of these genes on colon cancers[15]. In order
to further investigate the pathogenic mechanism of colon, we
examined the instability of D17S396 of nm23H1 in
unrelated patients with the single strand conformation polymorphism
analysis of polymerase chain reaction products (PCR-SSCP).
MATERIALS AND METHODS
Case selection and extraction of DNA
Thirty-two specimens were obtained during 2000 to 2002.
There were 21 males and 11 females, aged 27-77 years. Twenty-seven
cases were patients with tubular adenocarcinoma,
5 cases were patients with mucoid adenocarcinoma in
histological types. A senior pathologist made the final diagnosis on
the basis of histological examination. No patient received
radioactive therapy, chemotherapy before operation. Fresh surgical
tissue samples were fixed immediately in formaldehyde solution for
12-24 h and paraffin-embedded for PCR-SSCP and immunohistochemical
assay.
DNA extraction
DNA was extracted according to the standard protocols.
PCR amplification
Designed primers were synthesized by Shanghai Shengyou
Biology Company. The primer sequences were (sense) 5’-
TTGACCGGGGTAGAGAACTC –3’, (antisense) 5’- TCTCAGTACTTCCCGTGACC
–3’. PCR mixture contained 200 ng of template-DNA and PCR
reaction buffer containing 50 mmol/L KCl, 10 mmol/L Tris-HCl (pH
8.4), 1.5 mmol/L MgCl2, 0.5 mmol/L
each of two fragment-specific primers, 100 mmol/L
each of dATP, dGTP, dTTP and dCTP, and 2 units of Taq DNA polymerase
(Shanghai Shengyou Biology Company) for a reaction volume of 50 mL.
The conditions for all PCR amplifications were at 94 °C for 5 min for pre-denaturation, at 94 °C for 45 s, at 62 °C for 45 s and at 72 °C for 45 s. Amplification was carried out for 35 cycles with a
final extension for 10 min at 72 °C. The amplified fragments were run in 1% agarose gel.
SSCP analysis
SSCP analysis of fragments was performed on a mini
electropho-resis Unit (Bio-Rad Company, USA). Ten microlitre of the
PCR product was diluted with 10 mL
of sample buffer containing 90% formamide, 0.05% bromphenol blue dye
and 0.05% xylene cyanol. The samples were heated at 100 °C for 8 min, transferred into an ice-cold water bath for 3 min,
and analysed by 8% PAGE in 45 mmol/L-Tris-borate (pH8.0)/1 mmol/L-EDTA
(TBE) buffer under 13 v/cm at 10 °C.
DNA silver staining
Gels were stained with silver as follows. Gels were firstly
fixed in 100 mL/L alcohol for 10 min and then oxidized in 100 mL/L
nitric acid for 3 min. After washed for 1 min with double distilled
water, they were stained in 2 g/L silver nitric acid for 5 min and
washed for 1 min with double distilled water. Gels showed
appropriate color in 15 g/L anhydrous sodium carbonate and 4 mL/L
formalin and then the reaction was terminated by 7.5 mL/L glacial
acetic acid. Finally they were washed with double distilled water.
Immunohistochemical assay
Immunohistochemical study was performed using Envision
method. Briefly, 5 mm
thick sections of the tissue were deparaffinized and rehydrated.
Endogenous peroxidase activity was blocked with 3% hydrogen peroxide
for 20 min. After three times of rinsing with 0.01 mol/L
phosphate-buffered saline (PBS) (pH = 7.4), the slides were
incubated with 10% normal goat serum at room temperature for 10 min
to block the nonspecific reaction, and incubated for two hours with
anti-ICAM-1 antibody. After rinsed in PBS for five min, they were
incubated with Envision complex for two hours at room temperature,
and stained with DAB after washed in PBS.
Statistical analyses
The experimental results were expressed as mean±SD. The
correlation was analyzed with SPSS 8.0 software. P value less than
0.05 was regarded as statistically significant.
RESULTS
Expression of ICAM-1 in lymphatic endothelial cells
In the submucosa of normal colon, there existed a few
lymphatic vessels with large, irregular cavities and thin walls.
Simple squamous epithelia lined on them had no expression of ICAM-1
(Figure 1A). But in the submucosa and peripheral area of colon
cancer, the number of lymphatic vessels was increased. Significant
differences existed between them (P<0.01) (Table1). The
expression of lymphatic endothelial cell was positive for ICAM-1 in
colon cancer (Figure 1B). With the degree of cancer invasion,
lymphatic vessels positive for ICAM-1 showed an increasing trend (P<0.01)
(Table 2). When cancer metastasis appeared in the peripheral lymph
node, ICAM-1 was strongly expressed in endothelial cells of their
peripheral lymphatic vessels, and the number of lymphatic vessels
positive for ICAM-1 was to the highest (Table 2).
Table 1
Comparison of ICAM-1 expression between colon cancer and
normal colon (mean±SD)
| Group |
Cases |
ICAM-1/15HPF |
| Normal
colon |
5 |
11.001±1.58 |
| Colon
cancer |
32 |
26.131±9.19b |
aP<0.05,
bP<0.01, vs normal colon group.
Table
2 ICAM-1 expression
in colon cancer (mean±SD)
| Dukes
stage
|
Cases
|
ICAM-1
|
ICAM-1/15HPF
|
P Value
|
| Low-expression
|
High-expression
|
| A
|
5
|
3
|
2
|
19.671±5.59
|
|
| B
|
15
|
6
|
9
|
23.571±9.65
|
|
| C
|
10
|
3
|
7
|
25.591±8.07
|
<0.01
|
| D
|
2
|
0
|
2
|
35.681±2.51
|
|
| Metastasis
|
12
|
3
|
9
|
28.091±8.33
|
|
| No
metastasis
|
20
|
11
|
9
|
22.621±8.99
|
|
Table
3 Relationship
between clinical pathological parameter and nm23H1
genetic instability in colon cancer (mean±SD)
|
Cases
|
MSI(%)
|
LOH(%)
|
nm23(%)
|
nm23 expression
|
| Histological
types
|
30
|
8 (26.67)
|
6 (20.00)
|
16 (53.33)
|
40.21±3.29
|
| Tubular
adenocarcinoma
|
25
|
7 (28.00)
|
5 (20.00)
|
15 (60.00)
|
40.76±2.74
|
| High
differentiation
|
8
|
2 (25.00)
|
1 (12.50)
|
8 (100.00)
|
41.49±2.01
|
| Intermediate
differentiation
|
13
|
5 (38.46)
|
2 (15.38)
|
6 (46.15)
|
40.41±1.98
|
| Poor
differentiation |
4 |
0 (0.00) |
2 (50.00) |
1 (25.00)d |
40.18±2.17 |
| Mucoid
adenocarcinoma |
5 |
1 (20.00) |
1 (20.00) |
1 (20.00)b |
39.53±2.61 |
| TNM
stage
|
|
|
|
|
|
| Stage
I+II
|
16
|
7 (43.75)
|
1 (6.25)
|
13 (81.25)
|
42.42±1.08
|
| Stage
III+IV |
14 |
1 (7.14)e |
5 (35.71)e |
3 (21.43)f |
39.49±2.57 |
| Dukes
stage
|
|
|
|
|
|
| A
|
5
|
2 (40.00)
|
0 (0.00)
|
4 (80.00)
|
41.32±2.18
|
| B
|
15
|
5 (33.33)
|
3 (20.00)
|
8 (53.33)
|
40.69±2.11
|
| C
|
8
|
1 (12.50)
|
1 (12.50)
|
4 (50.00)
|
42.32±1.66
|
| D |
2 |
0 (0.00) |
2 (100.0)h |
0 (0.00) |
39.24±2.32 |
aP<0.05,
bP<0.01, vs
tubular adenocarcinoma group; cP<0.05,
dP<0.01 vs
high differentiation group; eP<0.05,
fP<0.01, vs
stage I+II group; gP<0.05,
hP<0.01 vs
A, B, C groups respectively.
Figure
1 Expression of
ICAM-1 in lymphatic endothelial cells. A: Negative expression of
ICAM-1 in the lymphatic endothelium (L) of normal colon and positive
expression of ICAM-1 in blood vessel endothelium (arrow) (Envision,
original magnification ×400); B: Positive expression of ICAM-1 in
the lymphatic endothelium (arrow) of colon cancer (Ca) (Envision,
original magnification ×400).
Figure
2(PDF)
Positive D17S396 MSI, LOH and nm23H1
in 30 cases of colon cancer. A: Positive MSI (arrow-headed) with an
additional allele band (1C) compared with normal tissue (1N); B:
Positive MSI (arrow-headed) with a removed allele band (4C) compared
with normal tissue (4N); C: Positive LOH (arrow-headed) with a
lacked allele band (9C) compared with normal tissue (9N); D:
Positive nm23H1
protein (arrow-headed) in cytoplasm, and nucleoli and membranes
(Envision, original magnification ×200).
Genetic instability at D17S396 of nm23H1
Microsatellite fragments of D17S396 were amplified. The
positive rate of D17S396 MSI (Figures 2A, B), LOH (Figure 2C) and
nm23H1 protein (Figure 2D) was 26.67%, 20.00% and 53.33%
respectively in 30 cases of colon cancer (Table 3).
MSI and LOH were
independent of the histological type of colon cancer, the degree of
differentiation and Duke’s stage were related to the clinical TNM
stage. In TNM staging, the frequency of MSI (43.75%) in stages I+II
was more than that in stages III+IV (7.14%, P<0.05). In
contrast, LOH (35.71%) in stages III+IV was detected more easily
than that (6.25%, P<0.05) in stages I+II. In addition, LOH
exhibited an ascending trend with the Duke’s stage (P<0.01).
Expression of nm23H1
protein
The positive rate of nm23H1 protein was related
with the histological type of colon cancer, differentiation degree
and clinical stage. The expression of nm23H1 protein in
the group of tubular adenocarcinoma (60.00%) was apparently higher
than that in the group of mucoid adenocarcinoma (20.00%, P<0.01),
and exhibited a rising trend with the differentiation degrees of
tubular adenocarcinoma (P<0.01). The positive rate of
nm23H1 in stages I+II (81.25%) was greater than that in
stages III+IV (21.43%) (P<0.01). The same phenomenon
occurred between the group positive for MSI (75%) and the group
negative for MSI (45.45%) (P<0.05) (Table 4). However, LOH
had no effect on the expression of nm23H1 protein (Table
4). Computer imaging analysis showed that there was a difference
among the groups in nm23H1 protein expression level.
Table 4 Relationship
between LOH, MSI and nm23 protein expression (mean±SD)
|
Groups
|
Cases
|
Expression of
nm23 protein(%)
|
Intensity of nm23 protein
|
| Positive
to MSI
|
8
|
6/8 (75.00)
|
39.06±2.14
|
| Negative
to MSI
|
22
|
10/22(45.45)
|
41.14±2.36
|
| Positive
to LOH
|
6
|
2/6 (33.33)
|
41.23±2.27
|
| Negative
to LOH
|
24
|
14/24 (58.33)
|
39.44±2.52
|
DISCUSSION
Metastasis,
the spread of cells from primary neoplasms to distant sites and
their growth at that location, is the most harmful aspect of cancer.
Despite great improvements in early diagnosis, surgical techniques,
general patient care, local and systemic adjuvant therapies, most
deaths from cancer are attributable to metastases that are resistant
to conventional therapies. During metastatic cascade, tumor cells
interact with various host cells as well as extracellular matrices
and basement membrane components including laminin, fibronectin, and
type I collagen through certain adhesion molecules such as integrins.
Such adhesive interactions may lead to the enhancement of survival,
arrest, or invasiveness of tumor cells and is one of the most
important events in the metastatic process[14-17].
Intercellular adhesion
molecule-1 (ICAM-1) is a single tran-smembrane
glycoprotein and has two patterns in the body. One is located on the
endothelial cells of blood vessels and is consisted of outmembrane
region, transmembrane region and cytoplasmic region. The other
(sICAM-1) is soluble in serum and is consisted of extracellular
domains and originates from leucocytes, endothelial cells and
hepatocytes[18-20]. The specific ligand of ICAM-1, LFA-1, can be
expressed on the surfaces of leucocytes and lymphocytes. In normal
conditions, ICAM-1/LFA-1 plays an important role in various immune
responses.
How ICAM-1 expresses when
tumors appear in the body? In the present case, ICAM-1 was expressed
on endothelial cells of lymphatic vessels in colon cancer. With the
degree of cancer invasion, lymphatic vessels positive for ICAM-1
showed an increasing trend. When cancer metastasis appeared in
peripheral lymph nodes, ICAM-1 was strongly expressed on endothelial
cells of peripheral lymphatic vessels, and the number of lymphatic
vessels positive for ICAM-1 was the highest. The results might give
a hint that cancer cells can be transferred into lymphatic vessels
in combination with LFA-1. Furthermore, sICAM-1 transformed from
ICAM-1 could inhibit natural killer cells, which could activate
lymphocytes and restrict major histocompatibility complex (MHC) to
react with T cells and tumor cells, thus promoting tumor cells to
escape[21-23]. Therefore, sICAM-1 could strengthen and promote
cancer cells to survive and transfer in lymphatic vessels when tumor
metastasis occurred.
Genetic instability is
the main reason why tumors appear and transfer[24-31]. MSI and LOH
could induce canceration in the body. MSI was firstly found in
hereditary non-polyposis colorectal cancer (HNPCC), and then in some
kinds of sporatic tumors such as colon cancer, gastric cancer,
uterus cancer, breast cancer, prostate cancer and pancreatic cancer.
Our results showed that DNA from thirty Chinese patients at the site
of D17S396 appeared microsatellite instability, the incidence was
26.67%. Subsequent experiments indicated that the incidence of MSI
at the site of D17S396 in the stage of TNM I+II was greater than
that in the stage of TNM III+IV, suggesting that MSI might be one of
the markers for early colon cancer.
In contrast to MSI, the
incidence of LOH at the site of D17S396 increased with the degree of
Duke stage. Therefore, our results made it clear that LOH of nm23H1
appeared at the later stage of colon cancer, which endowed colon
cancer with a high invasiveness and a poor prognosis.
The expression of nm23H1
has a negative relationship with tumor metastasis. Leone et al.[32]
found that nm23H1 had a function on the prevention of tumor
metastasis by inhibiting the ability of cancer cells to clone. With
the degree of tumor stage, the expression of nm23H1 decreased. Our
results indicate that with the development of colon cancer, the
expression of nm23H1 decreases.
REFERENCES
1
Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Failure of cancer
vaccines: the significant limitations of this approach to
immunotherapy. Anticancer Res 2000; 20: 2665-2676
2
Dudda JC, Simon JC, Martin S. Dendritic cell immunization
route determines CD8+ T cell trafficking to inflamed skin:
role for
tissue microenvironment and dendritic cells in establishment of T
cell-homing subsets. J Immunol
2004; 172: 857-863
3
Launay D, Peyrat JP, Verdiere A, Hornez L, Hatron PY,
Hachulla E, Devulder B, Hebbar M. Multiplex reverse transcription
polymerase chain reaction assessment of sialyltransferase expression
in peripheral blood mononuclear cells in systemic
sclerosis. J
Rheumatol 2004; 31: 88-95
4
Perdikogianni CH, Dimitriou H, Stiakaki E, Markaki EA,
Kalmanti M. Adhesion molecules, endogenous granulocyte
colony-stimulating factor levels and replating capacity of
progenitors in autoimmune neutropenia of childhood. Acta
Paediatr
2003; 92: 1277-1283
5
Kwei S, Stavrakis G, Takahas M, Taylor G, Folkman MJ,
Gimbrone MA Jr, Garcia-Cardena G. Early adaptive responses
of the
vascular wall during venous arterialization in mice. Am J Pathol
2004; 164: 81-89
6
Benkoel L, Dodero F, Hardwigsen J, Benoliel AM, Bongrand P,
Botta-Fridlund D, Le Treut YP, Chamlian A, Lombardo D.
Expression of
intercellular adhesion molecule-1 (ICAM- 1) during ischemia-reperfusion
in human liver tissue allograft:
image analysis by confocal laser
scanning microscopy. Dig Dis Sci 2003; 48: 2167-2172
7
Nyska A, Moomaw CR, Ezov N, Shabat S, Levin-Harrus T, Nyska
M, Redlich M, Mittelman M, Yedgar S, Foley JF. Ocular
expression of
vascular cell adhesion molecule (VCAM-1) in 2-butoxyethanol-induced
hemolysis and thrombosis in
female rats. Exp Toxicol Pathol 2003;
55: 231-236
8
Somersalo K, Anikeeva N, Sims TN, Thomas VK, Strong RK, Spies
T, Lebedeva T, Sykulev Y, Dustin ML. Cytotoxic T
lymphocytes form an
antigen-independent ring junction. J Clin Invest 2004; 113: 49-57
9
Chattopadhyay R, Taneja T, Chakrabarti K, Pillai CR, Chitnis
CE. Molecular analysis of the cytoadherence phenotype of
a
Plasmodium falciparum field isolate that binds intercellular
adhesion molecule-1. Mol Biochem Parasitol
2004; 133: 255-265
10
Einstein O, Karussis D, Grigoriadis N, Mizrachi-Kol R, Reinhartz E,
Abramsky O, Ben-Hur T. Intraventricular
transplantation of neural
precursor cell spheres attenuates acute experimental allergic
encephalomyelitis. Mol Cell
Neurosci 2003;24: 1074-1082
11
Toyama H, Takada M, Suzuki Y, Kuroda Y. Brain death-induced
expression of ICAM-1 and VCAM-1 on rat hepatocytes.
Hepatogastroenterology 2003; 50: 1854-1856
12
Vasse M, Thibout D, Paysant J, Legrand E, Soria C, Crepin M.
Decrease of breast cancer cell invasiveness by sodium
phenylacetate (NaPa) is associated with an increased expression of adhesive
molecules. Br J Cancer 2001; 84: 802-807
13
Soufir N, Daya-Grosjean L, de La Salmoniere P, Moles JP, Dubertret
L, Sarasin A, Basset-Seguin N. Association between
INK4a-ARF and p53
mutations in skin carcinomas of xeroderma pigmentosum patients. J
Natl Cancer Inst
2000; 92: 1841-1847
14
Berney CR, Fisher RJ, Yang J, Russell PJ, Crowe PJ. Genomic
alterations (LOH, MI) on chromosome 17q21-23 and
prognosis of
sporadic colorectal cancer. Int J Cancer 2000; 89: 1-7
15
Chow NH, Liu HS, Chan SH. The role of nm23H1 in the
progression of transitional cell bladder cancer. Clin Cancer Res
2000; 6: 3595-3599
16
Kawamura A, Miura S, Murayama T, Iwata A, Zhang B, Nishikawa
H, Tsuchiya Y, Matsuo K, Tsuji E, Saku K. Increased
Expression of
Monocyte CD11a and intracellular adhesion molecule-1 in patients
with initial atherosclerotic coronary
stenosis. Circ J 2004; 68:
6-10
17
Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ.
Maturation of DC is associated with changes in motile
characteristics and adherence. Cell Motil Cytoskeleton 2004; 57:
118-132
18
DesJardin LE, Kaufman TM, Potts B, Kutzbach B, Yi H, Schlesinger LS.
Mycobacterium tuberculosis-infected human
macrophages exhibit
enhanced cellular adhesion with increased expression of LFA-1 and
ICAM-1 and reduced
expression and/or function of complement
receptors, FcgammaRII and the mannose receptor. Microbiology
2002;
148(Pt 10): 3161-3171
19
Masamune A, Sakai Y, Kikuta K, Satoh M, Satoh A, Shimosegawa
T. Activated rat pancreatic stellate cells express
intercellular
adhesion molecule-1 (ICAM-1) in vitro. Pancreas 2002; 25: 78-85
20
Becker A, van Hinsbergh VW, Jager A, Kostense PJ, Dekker JM, Nijpels
G, Heine RJ, Bouter LM, Stehouwer CD. Why is
soluble intercellular
adhesion molecule-1 related to cardiovascular mortality? Eur J Clin
Invest 2002; 32: 1-8
21
Rescigno M, Valzasina B, Bonasio R, Urbano M, Ricciardi-Castagnoli
P. Dendritic cells, loaded with recombinant bacteria
expressing
tumor antigens, induce a protective tumor-specific response. Clin
Cancer Res 2001; 7(3 Suppl): 865S-870S
22
Zhou Y, Bosch ML, Salgaller ML. Current methods for loading
dendritic cells with tumor antigen for the induction of
antitumor
immunity. J Immunother 2002; 25: 289-303
23
Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Xiangming C, Iwashige H,
Aridome K, Hokita S, Aikou T. Clinical impact
of intratumoral
natural killer cell and dendritic cell infiltration in gastric
cancer. Cancer Lett 2000; 159: 103-108
24
Storchova Z, Pellman D. From polyploidy to aneuploidy, genome
instability and cancer. Nat Rev Mol Cell Biol
2004; 5: 45-54
25
Ko EC, Wang X, Ferrone S. Immunotherapy of malignant diseases.
Challenges and strategies. Int Arch Allergy Immunol
2003; 132:
294-309
26
Kleist B, Junghans D, Lorenz G, Bankau A, Poetsch M. The
supplementary diagnostic power of selected
immunohistochemical,
molecular genetic and infective parameters in epithelial
hyperplastic laryngeal lesions. Oncology
2003; 65: 347-354
27
Kovesi G, Szende B. Changes in apoptosis and mitotic index, p53 and
ki67 expression in various types of oral
leukoplakia. Oncology 2003;
65: 331-336
28
Hayashi H, Furihata M, Kuwahara M, Kagawa S, Shuin T, Ohtsuki Y.
Infrequent alteration in the P53R2 gene in human
transitional cell
carcinoma of the urinary tract. Pathobiology 2004; 71: 103-106
29
Bai Y, Murnane JP. Telomere instability in a human tumor cell line
expressing NBS1 with mutations at sites
phosphorylated by ATM. Mol
Cancer Res 2003; 1: 1058-1069
30
Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR.
Histopathological identification of colon cancer with
microsatellite
instability. Am J Pathol 2001; 158: 527-535
31
Rouba A, Kaisi N, Al-Chaty E, Badin R, Pals G, Young C, Worsham MJ.
Patterns of allelic loss at the BRCA1 locus in
Arabic women with
breast cancer. Int J Mol Med 2000; 6: 565-569
32 Leone A, Flatow U, van Houtte K, Steeg PS. Transfection of human
nm23-H1 into the human MDA-MB-435 breast
carcinoma cell line:
effects on tumor metastatic potential, colonization and enzymatic
activity. Oncogene
1993; 8: 2325-2333
Edited
by
Wang XL and Zhang JZ Proofread
by Xu FM
| |